Further Information
Cdkn2a, cyclin-dependent kinase inhibitor 2A, RP23-166I8.5, ARF-INK4a, Arf, INK4a-ARF, Ink4a/Arf, MTS1, Pctr1, p16, p16(INK4a), p16INK4a, p19ARF, CDK4I, OTTMUSP00000008143, cyclin-dependent kinase 4 inhibitor A, cyclin-dependent kinase inhibitor 2A (p16, inhibits CDK4), cyclin-dependent kinase inhibitor 2A, isoforms 1/2, cyclin-dependent kinase inhibitor protein, mitochondrial smARF, p16-INK4, p16-INK4a
Peptide ELISA: antibody detection limit dilution 1:64000.Western Blot:Approx 18kDa band observed in Mouse and Rat Liver lysates (calculated MW of 19.2kDa according to Mouse NP_034007.1 and 17.4kDa according to Rat NP_113738.1). Recommended concentration: 0.3-1ug/ml.
Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Aliquot and store at -20?C. Minimize freezing and thawing.
500 ug/mL
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
The immunogen for this antibody is: C-RRGPHRNPGPGDDD
12578 (mouse);
cyclin-dependent kinase inhibitor 2A
Cdkn2a
Mus musculus
Liquid
PREDICTED MOLECULAR WEIGHT:
Approx 18 kDa
NP_034007.1
6753390
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
This antibody is expected to recognize isoform p19ARF (NP_034007.1) only.
P51480